{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-secondary-use-of-clinical-trial-data-research-sharing”
},
“headline”: “SOP for Secondary Use of Clinical Trial Data (Research Sharing)”,
“description”: “This SOP defines procedures for the secondary use of clinical trial data, including governance for research sharing, anonymization, repositories submission, and compliance with FDA, EMA, CDSCO, WHO, GDPR, HIPAA, and ICH GCP guidelines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Secondary Use of Clinical Trial Data (Research Sharing)

Purpose

The purpose of this SOP is to establish governance and procedures for the secondary use of clinical trial data, also referred to as research sharing. It ensures subject privacy, ethical compliance, and regulatory adherence when trial data is reused for new analyses, meta-analyses, or submissions to regulatory repositories.

Scope

This SOP applies to sponsors, investigators, CROs, regulatory affairs teams, and data managers engaged in sharing or reusing clinical trial data for secondary purposes. It covers consent, anonymization, governance, repository submission, subject rights, data retention, and regulatory inspection readiness.

Responsibilities

• Sponsor: Oversees data sharing strategy, ensures data anonymization, and compliance with global data sharing policies.
• Investigator: Ensures subject consent allows secondary data use and provides trial-specific context for reuse.
• CRO: Monitors and supports data anonymization and submission processes.
• Data Manager: Prepares datasets, applies quality checks, and ensures secure transfer.
• QA: Audits secondary use data processes and maintains inspection readiness.
• Data Protection Officer: Ensures GDPR/HIPAA compliance and manages subject rights requests.

Accountability

The Sponsor’s Data Governance Lead is accountable for ensuring compliance with secondary use of data governance. Data Managers are accountable for the integrity of anonymized data sets.

Procedure

1. Consent and Governance
1.1 Confirm subject consent includes provisions for secondary use of data.
1.2 Document in Secondary Use Consent Log (Annexure-1).

2. Anonymization and Pseudonymization
2.1 Remove personal identifiers from datasets.
2.2 Apply pseudonymization techniques where necessary.
2.3 Record in Data Anonymization Log (Annexure-2).

3. Data Preparation and Quality Checks
3.1 Extract datasets required for secondary analysis.
3.2 Apply quality control checks to ensure accuracy.
3.3 Record in Data Preparation Log (Annexure-3).

4. Repository Submission
4.1 Submit anonymized datasets to regulatory or research repositories (e.g., ClinicalStudyDataRequest, WHO ICTRP).
4.2 Maintain Repository Submission Log (Annexure-4).

5. Subject Rights
5.1 Respond to subject requests for access, withdrawal, or deletion of data.
5.2 Record in Subject Rights Log (Annexure-5).

6. Data Security
6.1 Transfer data using secure encrypted channels.
6.2 Store shared data in validated systems.
6.3 Record in Data Security Log (Annexure-6).

7. Archiving
7.1 Archive secondary use datasets, anonymization records, and submission documents in TMF and ISF.
7.2 Retain per global regulatory timelines.

Abbreviations

• SOP: Standard Operating Procedure
• CRO: Contract Research Organization
• QA: Quality Assurance
• DPO: Data Protection Officer
• ISF: Investigator Site File
• TMF: Trial Master File
• GDPR: General Data Protection Regulation
• HIPAA: Health Insurance Portability and Accountability Act
• FDA: Food and Drug Administration
• EMA: European Medicines Agency
• CDSCO: Central Drugs Standard Control Organization
• WHO: World Health Organization

Documents

1. Secondary Use Consent Log (Annexure-1)
2. Data Anonymization Log (Annexure-2)
3. Data Preparation Log (Annexure-3)
4. Repository Submission Log (Annexure-4)
5. Subject Rights Log (Annexure-5)
6. Data Security Log (Annexure-6)

References

• FDA – Data Sharing and Standards
• EMA – Clinical Data Publication
• CDSCO – Clinical Data Sharing Rules
• WHO – Clinical Trials Data Sharing Policy
• ICH GCP – Data Transparency Standards

Version: 1.0

Approval Section

Annexures

Annexure-1: Secondary Use Consent Log

Annexure-2: Data Anonymization Log

Annexure-3: Data Preparation Log

Annexure-4: Repository Submission Log

Annexure-5: Subject Rights Log

Annexure-6: Data Security Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Data-Privacy-Rights-in-Consent-and-Withdrawals”
},
“headline”: “SOP for Data Privacy Rights in Consent and Withdrawals”,
“description”: “This SOP outlines regulatory-compliant procedures to safeguard data privacy rights during informed consent and participant withdrawals, ensuring compliance with GDPR, HIPAA, ICH GCP, FDA, EMA, CDSCO, and WHO requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Data Privacy Rights in Consent and Withdrawals

Purpose

The purpose of this SOP is to define procedures for ensuring participant data privacy rights during the informed consent process and in the event of consent withdrawal. This includes compliance with international data protection laws such as GDPR (EU), HIPAA (USA), ICH-GCP, as well as national regulations (e.g., CDSCO in India, EMA in Europe, and FDA in the USA).

Scope

This SOP applies to all investigators, site staff, data managers, IT administrators, and sponsors involved in the handling, processing, storage, and sharing of participant data in clinical trials. It also applies to procedures for responding to participant requests to withdraw consent or limit data use.

Responsibilities

• Principal Investigator (PI): Ensures participants are fully informed of their data privacy rights.
• Study Coordinator: Maintains accurate logs of consent and withdrawal requests.
• Data Protection Officer (DPO): Ensures compliance with GDPR, HIPAA, and local privacy regulations.
• IT/Data Management Team: Ensures secure storage, anonymization, and restricted access to participant data.
• Quality Assurance Officer: Conducts audits of data handling practices.

Accountability

The sponsor and Principal Investigator are accountable for ensuring that participants’ privacy rights are respected, and data protection measures are consistently implemented. Failure to comply may result in regulatory penalties and ethical violations.

Procedure

1. Informing Participants During Consent
Clearly explain to participants how their data will be collected, used, stored, and shared.
Provide details on data retention periods, cross-border data transfers, and rights to access their information.
Obtain explicit consent for sensitive data (e.g., genetic information).

2. Documentation of Consent
Record signed consent forms with specific checkboxes for data privacy agreements.
Maintain a Consent Documentation Log in the Trial Master File (TMF).

3. Withdrawal of Consent
Participants may withdraw consent at any time without penalty.
Document withdrawal request in writing and record in Withdrawal Log.
Discontinue collection of new data from the date of withdrawal.
Retain already collected data if permitted by regulations (e.g., to preserve trial integrity).

4. Data Anonymization and Pseudonymization
Code identifiers to protect subject identities.
Ensure re-identification is possible only by authorized personnel with secure keys.

5. Data Privacy Rights Management
Provide participants access to their data upon request.
Allow corrections, restrictions on use, or deletion in compliance with GDPR and local laws.
Respond to requests within regulatory timelines (e.g., 30 days under GDPR).

6. Data Security
Store electronic data in encrypted systems with access controls.
Restrict physical access to paper records.
Implement disaster recovery plans for backups and breaches.

7. Reporting and Compliance
Report breaches to regulatory authorities as per GDPR/HIPAA requirements.
Notify affected participants within mandated timelines.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• DPO: Data Protection Officer
• GDPR: General Data Protection Regulation
• HIPAA: Health Insurance Portability and Accountability Act
• TMF: Trial Master File
• QA: Quality Assurance

Documents

1. Consent Documentation Log (Annexure-1)
2. Consent Withdrawal Log (Annexure-2)
3. Data Access Request Form (Annexure-3)

References

• ICH E6(R2) – Good Clinical Practice
• General Data Protection Regulation (GDPR)
• US HIPAA Privacy Rule
• EMA Clinical Trial Regulation (EU No. 536/2014)
• CDSCO Clinical Trial Rules, 2019
• WHO – Guidance on Ethics in Health Research

Version: 1.0

Approval Section

Annexures

Annexure-1: Consent Documentation Log

Annexure-2: Consent Withdrawal Log

Annexure-3: Data Access Request Form

Revision History

For more SOPs visit: Pharma SOP